首页> 外文期刊>Science >SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions
【24h】

SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions

机译:SCS巨噬细胞通过限制肿瘤来源的小泡B细胞相互作用来抑制黑色素瘤

获取原文
获取原文并翻译 | 示例
       

摘要

Tumor-derived extracellular vesicles (tEVs) are important signals in tumor-host cell communication, yet it remains unclear how endogenously produced tEVs affect the host in different areas of the body. We combined imaging and genetic analysis to track melanoma-derived vesicles at organismal, cellular, and molecular scales to show that endogenous tEVs efficiently disseminate via lymphatics and preferentially bind subcapsular sinus (SCS) CD169(+) macrophages in tumor-draining lymph nodes (tdLNs) in mice and humans. The CD169(+) macrophage layer physically blocks tEVdissemination but is undermined during tumor progression and by therapeutic agents. A disrupted SCS macrophage barrier enables tEVs to enter the lymph node cortex, interact with B cells, and foster tumor-promoting humoral immunity. Thus, CD169(+) macrophages may act as tumor suppressors by containing tEV spread and ensuing cancer-enhancing immunity.
机译:肿瘤来源的细胞外囊泡(tEVs)是肿瘤与宿主细胞通讯的重要信号,但目前尚不清楚内源性产生的tEVs如何影响人体不同部位的宿主。我们结合影像学和遗传学分析在生物,细胞和分子水平上追踪黑色素瘤衍生的囊泡,以显示内源性tEV通过淋巴管有效扩散并优先结合肿瘤引流淋巴结(tdLNs)中的囊下窦(SCS)CD169(+)巨噬细胞。 )的小鼠和人类。 CD169(+)巨噬细胞层在物理上阻止tEV传播,但在肿瘤进展过程中被治疗剂破坏。破坏的SCS巨噬细胞屏障使tEV进入淋巴结皮质,与B细胞相互作用,并促进肿瘤促进体液免疫。因此,CD169(+)巨噬细胞可以通过包含tE​​V扩散并增强癌症免疫力来充当肿瘤抑制因子。

著录项

  • 来源
    《Science》 |2016年第6282期|242-246|共5页
  • 作者单位

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA|Torque Therapeut Inc, Cambridge, MA 02142 USA;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA|Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02115 USA;

    Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Res Inst, Charlestown, MA 02129 USA|Natl Tsing Hua Univ, Inst Biomed Engn, Hsinchu, Taiwan;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA|Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02115 USA;

    Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA|Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02115 USA;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA;

    Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA;

    Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland;

    Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Res Inst, Charlestown, MA 02129 USA;

    Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Res Inst, Charlestown, MA 02129 USA;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA;

    Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:38

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号